Targeted induction of the cold-shock protein RBM3 to prevent synapse loss and neurodegeneration in ALS/FTD

Project: Research

Project Details

StatusActive
Effective start/end date14/10/202413/05/2026

Funding

  • MRC Medical Research Council: £443,019.89